We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

E. coli Fingerprint Solves Cookie Dough Mystery

By LabMedica International staff writers
Posted on 25 Jun 2009
A genomic fingerprinting approach was used to identify the strain of the Escherichia coli O157:H7, which has been incriminated in the raw cookie dough scare in the United States. The E. coli O157:H7 is a strain not previously associated with eating raw cookie dough, but can be toxic to the kidney and in the worst cases, fatal.

The U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), the state health departments, federal regulatory partners, and many companies have been working together in the ongoing investigation to identify the E. coli strain responsible for the outbreak.

The CDC used a long polymerase chain reaction (PCR)-amplified ribosomal DNA (rDNA) for PCR restriction fragment length polymorphism (PCR-RFLP)- and Rep-PCR-based approach to recognize the culprit E.coli strain. Long PCR can be used to amplify fragments of bacterial ribosomal operons. Rep-PCR is a genomic fingerprinting method based on the use of DNA primers corresponding to naturally occurring interspersed repetitive elements in bacteria, such as the REP, ERIC, and BOX elements, and the PCR reaction (rep-PCR).

As of June 22, 2009, 70 persons infected with an E. coli O157:H7 with the DNA fingerprint of the strain have been reported from 30 states in the USA.

Related Links:

U.S. Centers for Disease Control and Prevention




New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Unit-Dose Packaging solution
HLX
New
Clostridium Difficile Assay
Revogene C. Difficile
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel

Latest Molecular Diagnostics News

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

Experimental Blood Test Improves Detection of Early-Stage Pancreatic Cancer